Filter
1933
Filtered Results: 1933
Text search:
drug
use
disorders
Featured
Recommendations
217
New Publications
420
Language
Document type
No document type
1265
Guidelines
244
Studies & Reports
238
Manuals
86
Strategic & Response Plan
36
Fact sheets
25
Training Material
21
Infographics
5
Brochures
4
Situation Updates
4
Resource Platforms
3
Dashboards/Maps
1
Online Courses
1
Countries / Regions
India
130
Global
61
Western and Central Europe
55
Ethiopia
47
South Africa
46
Kenya
42
Nigeria
35
Ukraine
31
Latin America and the Carribbean
28
Uganda
27
Eastern Europe
26
Philippines
25
Nepal
24
Rwanda
22
Tanzania
22
Bangladesh
22
Ghana
21
Liberia
21
Malawi
20
Africa
19
Zambia
19
Myanmar / Burma
19
Sierra Leone
17
Russia
16
Namibia
16
South–East Asia Region
13
USA
12
Indonesia
12
Eswatini/ Swaziland
11
Syria
10
Asia
10
Lesotho
9
Germany
8
Brazil
8
Botswana
8
Zimbabwe
7
Tajikistan
6
Haiti
6
South Sudan
6
Mozambique
5
Cambodia
5
Congo, Democratic Republic of
5
Middle East and North Africa
5
East and Southern Africa
5
North Macedonia
4
Cameroon
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Sudan
4
Georgia
4
China
3
Afghanistan
3
Belarus
3
Iraq
3
Thailand
2
Albania
2
Canada
2
Laos
2
Senegal
2
Kyrgyzstan
2
Jordan
2
Western Pacific Region
2
Jamaica
2
United Kingdom
2
Vietnam
2
Papua New Guinea
2
Moldova
2
Sri Lanka
2
Pakistan
2
Switzerland
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
Kazakhstan
1
Iran
1
Fiji
1
Singapore
1
Estonia
1
Burkina Faso
1
Uzbekistan
1
Peru
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Guinea
1
Armenia
1
Venezuela
1
Hungary
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Turkmenistan
1
Belgium
1
Tunisia
1
Southern Africa
1
Bolivia
1
Lebanon
1
Yemen
1
Greece
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Libya
1
Bhutan
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
632
Clinical Guidelines
190
Public Health
119
Women & Child Health
100
Capacity Building
37
Key Resources
22
Pharmacy & Technologies
15
Annual Report MEDBOX
1
Toolboxes
Mental Health
575
HIV
117
TB
83
NCDs
70
COVID-19
63
Pharmacy
53
Disability
43
NTDs
40
Refugee
37
Caregiver
36
Planetary Health
28
Conflict
26
Rapid Response
23
AMR
20
Global Health Education
19
Zika
15
Ebola
12
Specific Hazards
9
Natural Hazards
6
Polio
5
Social Ethics
4
Cholera
2
Health Financing Toolbox
2
The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs.
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
This handbook is intended primarily for front-line health care providers who are likely to see children (among other clients) in their day-to-day practice. These may include general practitioners, nurses, midwives, gynaecologists,
paediatricians, mental health professionals, first responders and st...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Since the beginning of the Ukraine crisis on 24 February 2022, WHO has supported Government-led efforts and initiatives alongside key partners on the ground. Building on efforts to date, and working alongside Bulgaria’s health authorities to bring added value to existing mechanisms, the WHO Countr...
Violence against women and girls is widespread in the Region of the Americas, resulting in enormous consequences for the health and wellbeing of women and girls, their families and communities. These costs are unacceptable and they can be prevented through evidence-based action, including the health...
La violencia contra las mujeres y las niñas es generalizada en la Región de las Américas, y tiene enormes consecuencias para su salud y bienestar, así como el de sus familias y sus comunidades. Se trata de un costo inaceptable que puede ser prevenido mediante acciones basadas en la evidencia, pr...
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards individuals with lived experience; informed decision-making and health literacy; community engagement ...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
Unmet mental health needs in the Region of the Americas are a leading source of morbidity and mortality, which result in tremendous health, social, and economic consequences. The COVID-19 pandemic has exacerbated the mental health crisis in the Region, necessitating urgent action at the highest leve...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy...
